CoStar Group, Inc.

Analysis of CoStar Group (CSGP)

Technical Analysis The stock is in a pronounced downtrend, having lost approximately a third of its value over the past three months and trading near its 52-week low. This severe underperformance, despite a beta suggesting lower volatility, points to strong negative momentum driven by company-specific issues. The deeply oversold condition indicates extreme pessimism, but without clear technical reversal signs, the near-term pressure remains.

Fundamental Analysis Revenue growth is positive but overshadowed by a sharp deterioration in profitability, with the company slipping into negative operating and net margins. While a strong liquidity position and low debt provide a financial buffer, negative interest coverage and declining cash flow highlight operational challenges. Key efficiency metrics like ROE and ROA are negative, signaling that the business is not effectively converting assets into earnings.

Valuation & Risk Valuation multiples are exceptionally high, particularly the trailing P/E over 180, which is difficult to justify given current losses, though the PEG ratio suggests future growth may offer some support. The lack of industry comparables makes relative valuation uncertain. Primary risks include high downside volatility evidenced by a maximum drawdown exceeding 50%, alongside profitability concerns that could persist if cost pressures are not managed.

Investment Recommendation

Based on the current analysis, CoStar Group (CSGP) is not a buy at this time. The severe price decline reflects justified concerns over deteriorating profitability and inefficient operations, despite a solid balance sheet. Until there is clearer evidence of sustained margin improvement and a reversal in negative earnings trends, the elevated valuation and technical weakness present significant downside risk. Investors should monitor upcoming earnings for signs of operational turnaround before considering a position.

RockFlow Model Forecast: Three Scenarios for 2026

Based on the current analysis, the 12-month outlook for CoStar Group (CSGP) is challenging. Key catalysts for a potential recovery hinge on clear operational improvements, specifically a demonstrated turnaround in profitability and a reversal of negative cash flow trends in upcoming earnings reports. The primary risks remain substantial, including persistent margin deterioration, the inability to justify its lofty valuation amid losses, and continued high downside volatility. While analyst targets are unavailable, the stock's current oversold condition near 52-week lows suggests a wide potential range; a successful operational turnaround could drive a significant rebound, but failure to address core profitability issues could lead to further downside.

Wall Street Consensus

Most Wall Street analysts are optimistic about CoStar Group, Inc.'s 12-month outlook, with consensus target around $44.99, indicating expected upside potential.

Overall, CSGP has investment potential but also faces challenges. Here are key factors to weigh before investing.

CSGP has experienced severe underperformance over the past year amidst a significant downtrend.

The stock has suffered dramatic losses, plunging approximately 30% over one month and 33% over three months, significantly underperforming the market by a similar margin (-33.13%) despite its beta of 0.85 suggesting it should be less volatile. This indicates substantial negative momentum and investor pessimism independent of broader market movements.

Currently trading at $44.99, CSGP is hovering just above its 52-week low of $43.92, placing it in deeply oversold territory. Given the maximum drawdown of -53.54% and its proximity to the annual low, the stock shows no signs of being overbought and reflects extreme negative sentiment.

Revenue & Profitability CSGP reported mixed quarterly results with Q3 revenue growing 6.7% sequentially to $834 million, though profitability deteriorated significantly. The company posted negative operating and net margins of -6.1% and -3.7% respectively in Q3, reversing from slightly positive figures in Q2. This suggests operating expenses are outpacing revenue growth, particularly in sales and marketing which consumed over 50% of revenue.

Financial Health The company maintains strong liquidity with current and quick ratios above 3.0, supported by substantial cash reserves representing $4.85 per share. However, the negative interest coverage ratio of -11.6 indicates EBIT is insufficient to cover interest expenses, though the low debt ratio of just 10.4% provides some cushion. Operating cash flow generation remains positive but declined materially from previous periods.

Operational Efficiency Operational metrics show challenges with ROE and ROA both negative at -0.36% and -0.29% respectively, reflecting profitability issues. Asset turnover remains low at 0.077, indicating inefficient utilization of the asset base to generate revenue. The cash conversion cycle of 6.3 days demonstrates efficient working capital management, though this is overshadowed by broader operational profitability concerns.

Based on the available metrics, CSGP appears significantly overvalued. Its trailing PE ratio of 182.99 is exceptionally high, indicating investors are paying a substantial premium for its current earnings. While the negative forward PE implies expected losses, the positive PEG ratio of 0.48—driven by anticipated earnings growth—suggests growth may partially justify the valuation, though the extreme EV/EBITDA of over 1,174 remains a major concern.

A peer comparison cannot be conducted as industry average data is not available. Without this contextual benchmark, it is impossible to determine if CSGP's elevated valuation multiples are an industry-wide phenomenon or unique to the company. This lack of comparative data limits the ability to make a conclusive relative valuation assessment.

Volatility Risk: With a beta of 0.85, CSGP exhibits slightly less volatility than the broader market, suggesting a moderately defensive profile. However, the significant one-year maximum drawdown of -53.54% indicates a high degree of downside risk and vulnerability to severe price declines during market downturns.

Other Risks: The absence of reported short interest suggests minimal active speculative bets against the stock, which can be viewed as a positive signal of market confidence. Nevertheless, investors should still assess standard risks such as company-specific operational performance and broader sector liquidity.